ProKidney Corp (NASDAQ:PROK) does about 705.99K shares in volume on a normal day but saw 1152575 shares change hands in Tuesday trading. The company now has a market cap of 155.90M USD. Its current market price is $2.53, marking a decrease of -6.99% compared to the previous close of $2.72. The 52 week high reached by this stock is $13.51 whilst the lowest price level in 52 weeks is $1.12.
ProKidney Corp (PROK) has a 20-day trading average at $1.87 and the current price is -81.27% off the 52-week high compared with 125.89% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.64 and its 200-day simple moving average is $4.07. If we look at the stock’s price movements over the week, volatility stands at 29.84%, which decreases to 16.88% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.02 to suggest the stock is neutral.
The consensus objective for the share price is $3.75, suggesting that the stock has a potential upside of 32.53% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 07, 2024 when Morgan Stanley resumed the stock to “Equal-Weight” and issued a price target of $3. BTIG Research initiated its price target at $16.
ProKidney Corp (PROK) stock is down -6.99% over the week and 80.71% over the past month. Its price is 42.13% year-to-date and -78.74% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -0.16 above consensus estimates by 0.23. The company’s next earnings report forecasts estimating quarterly EPS at 0 and -1.22 for whole year.
To reach the target analysts have set, the stock logically needs to grow 32.53 percent from here.
The beta has a value of 1.01.
